Scholarlink

<p>UK general practice is increasingly adopting ambient voice technology (“AI scribes”) for summarising and documenting medical consultations without clear regulation and implementation guidance. The aim of this study was to examine current use and perceptions of AI scribes among UK GPs, and to identify GP, practice, and population factors associated with their adoption. We conducted a cross-sectional online survey of UK GPs (<i>n</i> = 598) to examine current use, perceptions, and factors associated with adoption, analysed using logistic regression. AI scribes were used by 40% of GPs, with an additional 23% reporting past use. Use ranged from 5 to 100% of consultations (mean 60%). Adoption was more likely among men (OR = 1.64), GPs working in private practice (OR = 2.88) and 5–6 clinical sessions weekly (OR = 2.17), those with more experience (OR = 1.68), and GP trainers (OR = 3.10). Efficiency and timeliness were widely perceived benefits, while concerns about safety and medicolegal risks were common, particularly among non-users. Use of AI scribes in the UK is relatively high despite regulatory issues and recent official cease communication. Local population characteristics were not associated with use, but use varied significantly depending on GP characteristics. Selective use within practices and patient perspectives warrant further investigation to ensure equitable use of AI scribes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Use of AI scribes in UK primary care: a survey of general practitioners

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月16日

查看全文
  • Christina Derksen,
  • Mona Yekezare,
  • Thomas Round,
  • Suzanne E. Scott,
  • Fiona M. Walter

摘要

UK general practice is increasingly adopting ambient voice technology (“AI scribes”) for summarising and documenting medical consultations without clear regulation and implementation guidance. The aim of this study was to examine current use and perceptions of AI scribes among UK GPs, and to identify GP, practice, and population factors associated with their adoption. We conducted a cross-sectional online survey of UK GPs (n = 598) to examine current use, perceptions, and factors associated with adoption, analysed using logistic regression. AI scribes were used by 40% of GPs, with an additional 23% reporting past use. Use ranged from 5 to 100% of consultations (mean 60%). Adoption was more likely among men (OR = 1.64), GPs working in private practice (OR = 2.88) and 5–6 clinical sessions weekly (OR = 2.17), those with more experience (OR = 1.68), and GP trainers (OR = 3.10). Efficiency and timeliness were widely perceived benefits, while concerns about safety and medicolegal risks were common, particularly among non-users. Use of AI scribes in the UK is relatively high despite regulatory issues and recent official cease communication. Local population characteristics were not associated with use, but use varied significantly depending on GP characteristics. Selective use within practices and patient perspectives warrant further investigation to ensure equitable use of AI scribes.